
Adicet Bio Investor Relations Material
Latest events

Status Update
Adicet Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adicet Bio Inc
Access all reports
Adicet Bio Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies for cancer and other diseases. The company specializes in creating off-the-shelf genetically modified gamma delta T cells that selectively target tumors, leveraging the unique properties of these cells to offer a new generation of immune cell therapy. The company is headquartered in Redwood City, California, and its shares are listed on the Nasdaq.
Key slides for Adicet Bio Inc


9th Annual CAR-TCR U.S. Summit
Adicet Bio Inc


Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024
Adicet Bio Inc
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
ACET
Country
🇺🇸 United States